title: Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
authors.forename: R
authors.initials: R
authors.lastname: Selby
authors.forename: E
authors.initials: E
authors.lastname: Nisbet-Brown
authors.forename: R K
authors.initials: RK
authors.lastname: Basran
authors.forename: L
authors.initials: L
authors.lastname: Chang
authors.forename: N F
authors.initials: NF
authors.lastname: Olivieri
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood* / Q000150:complications* / Q000628:therapy; D000927:Anticonvulsants / Q000627:therapeutic use*; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002220:Carbamazepine / Q000627:therapeutic use; D002648:Child; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D012640:Seizures / Q000150:complications* / Q000188:drug therapy*; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D000986:Antisickling Agents; D006454:Hemoglobins; D002220:Carbamazepine; D014635:Valproic Acid; D005319:Fetal Hemoglobin; D006918:Hydroxyurea